Atrial Fibrillation in Elderly Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Atrial Fibrillation in Elderly
Atrial fibrillation (AFib) is a common heart rhythm disorder, especially prevalent among older adults. This condition can significantly increase the risk of serious health complications, such as stroke, if not properly managed. Effective treatment often involves ongoing medication, which can become a considerable financial burden. TheDrugClub offers a practical solution, helping seniors and their families access vital AFib prescriptions at a more affordable price.
Atrial fibrillation, often simply called AFib, is a type of irregular and often rapid heartbeat that can affect the heart's upper chambers (atria). Instead of beating in a coordinated rhythm, the atria quiver chaotically, leading to inefficient blood flow. This condition is particularly common in the elderly, with its prevalence increasing significantly with age. Factors contributing to AFib in older adults often include underlying heart disease, high blood pressure, diabetes, and other age-related changes to heart structure.
Symptoms of AFib can vary widely; some individuals may experience noticeable palpitations, shortness of breath, fatigue, dizziness, or chest pain, while others might have no symptoms at all. Despite the presence or absence of symptoms, AFib poses serious risks, most notably a five-fold increased risk of stroke due to blood clots forming in the heart and traveling to the brain. It can also lead to heart failure over time.
Managing AFib typically involves a multi-pronged approach, often requiring long-term medication. Common treatments include:
- Blood thinners (Anticoagulants): Medications like warfarin, dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa) are crucial for preventing blood clots and reducing stroke risk.
- Rate Control Medications: Beta-blockers (e.g., metoprolol) and calcium channel blockers (e.g., diltiazem) help slow the heart rate to a more normal pace.
- Rhythm Control Medications: Antiarrhythmic
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.